Literature DB >> 6187940

Differential antiviral effects of interferon in three murine cell lines.

G C Sen, R E Herz.   

Abstract

Infectious leukemia virus production by two chronically infected NIH/MOL lines was strongly inhibited by interferon treatment of the cells. The corresponding degree of inhibition in JLSV-11 cells was much lower. Multiplication of encephalomyocarditis virus in all three cell lines was barely affected by interferon treatment. Replication of vesicular stomatitis virus, on the other hand, was highly sensitive to interferon in the JLSV-11 line and in one NIH/MOL line but was practically insensitive in the other NIH/MOL line. Anticellular actions of interferon were more pronounced in the JLSV-11 line than in the others. In response to interferon treatment, 2',5'-oligoadenylate synthetase activity was induced to a high level in JLSV-11 cells and to lower levels in the NIH/MOL lines. We failed to detect any 2',5'-oligoadenylate-dependent endonuclease activity in extracts of these cells. Double-stranded RNA-dependent protein kinase activity was present in extracts of interferon-treated NIH/MOL cells, but it was barely detectable in extracts of interferon-treated JLSV-11 cells. The above studies demonstrated that interferon could differentially affect the replication of three different viruses in three different cell lines, including two seemingly identical NIH/MOL lines, and that certain tentative conclusions can be drawn regarding the roles of different interferon-inducible enzyme markers in the different antiviral actions of interferons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187940      PMCID: PMC256509     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Interferon, double-stranded RNA, and protein phosphorylation.

Authors:  B Lebleu; G C Sen; S Shaila; B Cabrer; P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

Review 2.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

3.  Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon.

Authors:  G C Sen; S Shaila; B Lebleu; G E Brown; R C Desrosiers; P Lengyel
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Effect of interferon on exogenous, endogenous, and chroniv murine leukemia virus infection.

Authors:  P M Pitha; W P Rowe; M N Oxman
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

6.  Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract.

Authors:  G C Sen; S L Gupta; G E Brown; B Lebleu; M A Rebello; P Lengyel
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

7.  Infection of an established mouse bone marrow cell line (JLS-V9) with Rauscher and Moloney murine leukemia viruses.

Authors:  B S Wright; P A O'Brien; G P Shibley; S A Mayyasi; J C Lasfargues
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

8.  Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers.

Authors:  R M Friedman; E H Chang; J M Ramseur; M W Myers
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

9.  Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.

Authors:  P T Allen; H Schellekens; L J Van Griensven; A Billiau
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

10.  The effect of interferon on de novo infection of Moloney murine leukemia virus.

Authors:  P K Wong; P H Yuen; R MacLeod; E H Chang; M W Myers; R M Friedman
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

View more
  10 in total

1.  Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.

Authors:  Mariana G Bego; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons.

Authors:  R Kumar; R K Tiwari; J Kusari; G C Sen
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

3.  Transcriptional analyses of interferon-inducible mRNAs.

Authors:  J Kusari; G C Sen
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

4.  Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.

Authors:  S Salzberg; D H Wreschner; F Oberman; A Panet; M Bakhanashvili
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

5.  Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.

Authors:  G C Sen; R Herz; V Davatelis; S Pestka
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  Inhibition of vesicular stomatitis viral mRNA synthesis by interferons.

Authors:  L S Belkowski; G C Sen
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  R Kumar; D Choubey; P Lengyel; G C Sen
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Expression of interferon-inducible genes in RD-114 cells.

Authors:  J Kusari; R K Tiwari; R Kumar; G C Sen
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

9.  Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element.

Authors:  C Bovolenta; J Lou; Y Kanno; B K Park; A M Thornton; J E Coligan; M Schubert; K Ozato
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine.

Authors:  A Turano; A Balsari; E Viani; S Landolfo; L Zanoni; F Gargiulo; A Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.